Organophosphate (OP) Poisoning: Treatment

Mechanism of Toxicity

Organophosphates inhibit acetylcholinesterase (AChE), causing accumulation of acetylcholine (ACh) at muscarinic, nicotinic, and CNS synapses. This produces an overwhelming cholinergic toxidrome. — Adams and Victor's Principles of Neurology, 12e

Clinical Features (SLUDGE + Nicotinic)

Muscarinic (SLUDGE/DUMBELS):

Salivation, Lacrimation, Urination, Defecation, GI cramps, Emesis
Bronchorrhea, bronchospasm, miosis, bradycardia, diaphoresis

Nicotinic:

Muscle fasciculations, weakness, paralysis (including respiratory muscles)
Tachycardia, hypertension (may mask bradycardia)

CNS:

Headache, anxiety, seizures, coma, altered mental status

Key diagnostic clue: pinpoint pupils + excessive secretions + altered consciousness + garlic/hydrocarbon odor. — Tintinalli's Emergency Medicine, 9e

Step-by-Step Treatment

1. Decontamination (Priority 1)

Healthcare workers must wear PPE — secondary contamination is a real risk
Remove and bag all clothing (treat as hazardous waste)
Wash skin thoroughly with soap and water; treat runoff as hazardous waste
If ingested: gastric lavage and activated charcoal have no proven benefit

2. Airway & Supportive Care

100% oxygen, continuous cardiac monitoring, pulse oximetry
Endotracheal intubation + mechanical ventilation in severe cases (atropine does not reverse muscle paralysis)
Avoid succinylcholine (prolonged paralysis due to inhibited plasma cholinesterase) and ester-type local anesthetics

3. Atropine (Antidote — Muscarinic Effects)

Atropine is a competitive antagonist at muscarinic receptors only. It does not reverse nicotinic (skeletal muscle) effects.

Parameter	Adult	Pediatric
Initial dose	1–3 mg IV (depending on severity)	0.05 mg/kg IV
Titration	Double every 5 min until atropinization	Same
Maintenance infusion	10–20% of total loading dose per hour	Same principle

Endpoint of atropinization (all three required):

Chest clear on auscultation (dry secretions) ← most important endpoint
Heart rate > 80 beats/min
Systolic BP > 80 mmHg

⚠️ Pupil dilation is NOT a treatment endpoint. Tachycardia is NOT a contraindication. Massive ingestions may require 200–500 mg in the first hour. — Rosen's Emergency Medicine, 10e; Tintinalli's, 9e

4. Pralidoxime / Oximes (AChE Reactivator)

Oximes bind the OP-AChE complex and reactivate the enzyme before irreversible "aging" occurs.

Parameter	Adult	Pediatric
Bolus	1–2 g IV over 30 min	25–50 mg/kg
WHO alternative	30 mg/kg bolus → 8 mg/kg/h infusion	—
Repeat dosing	Based on response (improved mental status, ↓ secretions)	—
Duration	Continue 24–48 h (up to 7 days in some protocols)	—

Key points:

Administer as early as possible — reverses muscle paralysis if given before aging
Still recommended even >24–48 h after exposure
Not recommended for asymptomatic patients or isolated carbamate exposure with mild symptoms
Current evidence is insufficient to definitively show oximes reduce mortality (ongoing controversy) — Tintinalli's, 9e; Rosen's, 10e

5. Benzodiazepines (Seizures)

First-line for OP-induced seizures
Atropine may prevent/abort early seizures; benzodiazepines are needed for established seizures
Use airway protection + oxygen simultaneously

Lab Investigations

Test	Role
Red cell AChE	More accurate marker of synaptic inhibition; <10–20% = severe poisoning
Plasma butyrylcholinesterase	Easier to assay; decreases first, normalizes in 28–42 days (without oximes)
ECG	QT prolongation, torsades, heart block
CXR	Pulmonary edema in severe cases
Glucose, LFTs, amylase	Nonspecific but may show pancreatitis, dysglycemia

Disposition

All significantly exposed patients → monitored bed (usually ICU)
Asymptomatic with normal/minimally depressed cholinesterase → observe 6 hours, discharge with follow-up
Rebound toxicity can occur days later (lipid-stored OP release; especially fenthion)
Psychiatric consultation for intentional overdose

Complications & Delayed Syndromes

Syndrome	Timing	Features
Intermediate Syndrome (IMS)	24–96 h after acute phase	Proximal muscle weakness, neck flexors, cranial nerve palsies, respiratory paralysis — does not respond to atropine
Delayed Polyneuropathy (OPIDP)	7–21 days after exposure	Distal sensorimotor neuropathy, may progress to corticospinal signs

Carbamates vs. Organophosphates

Carbamates (e.g., carbaryl) also inhibit AChE but with important differences:

Shorter duration (minutes to 48 h)
No aging — spontaneous AChE recovery
Atropinization is usually sufficient; pralidoxime use is controversial and generally reserved for severe/undifferentiated cases

Recent Evidence (2025)

Two recent systematic reviews/meta-analyses suggest investigational adjunctive roles for:

Magnesium sulfate and/or calcium channel blockers as co-adjuvants to standard atropine + pralidoxime therapy [PMID: 40792609]
Other adjunctive therapies in emergency management of OP poisoning [PMID: 40714568]

These are not yet standard of care but reflect active research into improving outcomes beyond the atropine/pralidoxime backbone.

Sources: Tintinalli's Emergency Medicine 9e; Rosen's Emergency Medicine 10e; Adams and Victor's Principles of Neurology 12e; Morgan & Mikhail's Clinical Anesthesiology 7e

This is a shared conversation. Sign in to Orris to start your own chat.